Use of IL-22 for the treatment of conditions of metabolic disorders
US7666402B2 · kind B2 · utility
10Cited by
8References
6Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 16, 2007 |
| Grant date | Feb 23, 2010 |
| Priority date | — |
| Expiry date | Nov 17, 2027 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K48/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The use of IL-22 for the treatment of metabolic disorders including hyperlipidemia, obesity, hyperinsulinemia and diabetes. IL-22 may also be used in combination with insulin for diabetes.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.